e-Drug3D

934

DECITABINE


INN
DECITABINE

cas 2353-33-5
CLASS

ANTINEOPLASTIC
ANTIMETABOLITES
TERATOGENS
TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
INDUCE HYPOMETHYLATION OF DNA

ROUTE (list)

INTRAVENOUS ORAL

ATC code

L01BC08
L01BC58

PK parameters

VD 299 LITER (65 KILOGRAM)
Cl 130 LITER / HOUR
PPB 0 PERCENT
t1/2 0.54 HOUR

Solubility

SPARINGLY SOLUBLE IN WATER


Target

TARGET DEOXYCYTIDINE KINASE

DrugCentral

DNA (cytosine-5)-methyltransferase 1 UNIPROT P26358 DNMT1

DNA (cytosine-5)-methyltransferase 3A UNIPROT Q9Y6K1 DNMT3A

Download SDF file 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one

Formula:
C8H12N4O4

Calculated chemical properties:

MW 228.22
NB_atoms 16
XLogP -2.14
PSA 118.789
NB_HD 4
NB_HA 8
fsp3 0.62
Lipinski(0=no;1=yes) 1

FDA
NDA 021790 (label) INN (DECITABINE) DACOGEN (OTSUKA) APPROVAL= AP YEAR= 2006 NEWMOLECULARENTITY DISCONTINUED
NDA 203131 (pdf not found) INN (DECITABINE) DECITABINE (DR REDDYS) APPROVAL= AP YEAR= 2013
NDA 202969 (pdf not found) INN (DECITABINE) DECITABINE (SANDOZ) APPROVAL= AP YEAR= 2014
NDA 205582 (label) INN (DECITABINE) DECITABINE (SUN PHARM) APPROVAL= AP YEAR= 2014
NDA 203475 (pdf not found) INN (DECITABINE) DECITABINE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2017
NDA 204607 (pdf not found) INN (DECITABINE) DECITABINE (PHARMASCIENCE INC) APPROVAL= AP YEAR= 2017
NDA 206033 (pdf not found) INN (DECITABINE) DECITABINE (CHEMI SPA) APPROVAL= AP YEAR= 2017
NDA 208601 (pdf not found) INN (DECITABINE) DECITABINE (CIPLA) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 207100 (pdf not found) INN (DECITABINE) DECITABINE (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2018
NDA 210756 (pdf not found) INN (DECITABINE) DECITABINE (LUPIN LTD) APPROVAL= AP YEAR= 2018
NDA 209056 (pdf not found) INN (DECITABINE) DECITABINE (WOCKHARDT BIO AG) APPROVAL= AP YEAR= 2019
NDA 210984 (pdf not found) INN (DECITABINE) DECITABINE (NOVAST LABS) APPROVAL= AP YEAR= 2019
NDA 212265 (pdf not found) INN (DECITABINE) DECITABINE (MSN) APPROVAL= AP YEAR= 2019
NDA 212576 (label) INN (CEDAZURIDINE ; DECITABINE) INQOVI (TAIHO ONCOLOGY) APPROVAL= AP YEAR= 2020
NDA 205539 (pdf not found) INN (DECITABINE) DECITABINE (GLAND) APPROVAL= AP YEAR= 2020
NDA 212117 (pdf not found) INN (DECITABINE) DECITABINE (NIVAGEN PHARMS INC) APPROVAL= AP YEAR= 2020
NDA 212826 (pdf not found) INN (DECITABINE) DECITABINE (QILU PHARM HAINAN) APPROVAL= AP YEAR= 2021
NDA 212959 (pdf not found) INN (DECITABINE) DECITABINE (MEITHEAL) APPROVAL= AP YEAR= 2021
NDA 214486 (pdf not found) INN (DECITABINE) DECITABINE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2021
NDA 214569 (pdf not found) INN (DECITABINE) DECITABINE (EUGIA PHARMA) APPROVAL= AP YEAR= 2021
NDA 213472 (pdf not found) INN (DECITABINE) DECITABINE (JIANGSU HANSOH PHARM) APPROVAL= AP YEAR= 2022
NDA 215355 (pdf not found) INN (DECITABINE) DECITABINE (HETERO LABS LTD VI) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL